NEPHRONET INC (EIN 453760055) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2010

Legal Domicile

Principal Officer

JAMES ALAN TUMLIN MD

Phone

4239434265

Tax Period

2023-01-01 to 2023-12-31

NEPHRONET INC, founded in 2010, is a community nonprofit in the Health Care sector that reported $4.4M in total revenue in fiscal year 2023. Expenses of $4.2M left a modest 3% surplus.

Mission

NEPHRONET IS A NETWORK OF DEDICATED CLINICIANS, INVESTIGATORS AND AFFILIATED SPONSORS THAT ARE COLLECTIVELY COMMITTED TO ADVANCING PATIENT EDUCATION, RESEARCH AND THE REALIZATION OF NEW METHODS TO TREAT KIDNEY DISEASE.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $4,367,108

Program Service Revenue $0

Investment Income $0

Other Revenue $0

TOTAL REVENUE $4,367,108

Expense Breakdown

Grants Paid $0

Salaries & Benefits $145,499

Fundraising Expenses $0

Program Expenses $3,976,371

Other Expenses $4,069,566

TOTAL EXPENSES $4,215,065

Year-over-Year Comparison

	2023	2022	Change
Revenue	$4,367,108	$4,334,687	+0.0%
Expenses	$4,215,065	$4,040,679	+0.0%
Net Income	$152,043	$294,008	-0.5%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

N/A

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
JAMES ALAN TUMLIN MD	EXECUTIVE DIRECTOR	010.00	Officer Director	$0	$0	$0
CLAUDE GALPHIN MD	DIRECTOR	005.00	Director	$0	$0	$0
BHUPINDER SINGH MD	DIRECTOR	005.00	Director	$0	$0	$0
BRAD ROVIN MD	DIRECTOR	005.00	Director	$0	$0	$0
RANDY HENNIGAR MD	DIRECTOR	005.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2024	No data	No data	No data	No data
2023	$4,367,108	$4,215,065	$560,403	$152,043
2022	$4,334,687	$4,040,679	$2,015,866	$294,008
2021	$881,735	$922,700	$129,385	$-40,965
2020	$420,311	$424,582	$133,156	$-4,271

NEPHRONET INC